Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12622000498796
Ethics application status
Approved
Date submitted
11/03/2022
Date registered
29/03/2022
Date last updated
10/07/2023
Date data sharing statement initially provided
29/03/2022
Type of registration
Prospectively registered
Titles & IDs
Public title
Diagnostic Accuracy and economic value of a Tiered Assessment (DATA) for Fetal Alcohol Spectrum Disorder (FASD)
Query!
Scientific title
Diagnostic Accuracy and economic value of a Tiered Assessment (DATA) for Fetal Alcohol Spectrum Disorder (FASD) in urban, rural, and remote Australia
Query!
Secondary ID [1]
306643
0
Nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
DATAforFASD
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Fetal Alcohol Spectrum Disorder
325586
0
Query!
Condition category
Condition code
Neurological
322951
322951
0
0
Query!
Other neurological disorders
Query!
Mental Health
322952
322952
0
0
Query!
Other mental health disorders
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Each participant will receive both a rapid and a comprehensive assessment of 9 neurodevelopmental domains: (motor, cognition, language, academic achievement, memory, attention, executive function, affect regulation, and adaptive function). Assessments will be delivered by appropriately trained health practitioners (e.g., speech pathologists, psychologists, paediatricians, general practitioners). Assessments will be delivered face-to-face where possible; tele-health appointments will be used when face-to-face appointments are not possible. Assessments for all domains will not be completed during one sitting. Participants will attend multiple sessions to complete all index and reference tests. All tests will be completed within 6 months of the first administered test. Assessments will be conducted at specialist clinics and primary care clinics in both urban and rural/remote settings. The anticipated duration of testing for all rapid tests will be about 1 hr. The anticipated duration of testing for all comprehensive tests will be about 8-10 hours.
Query!
Intervention code [1]
323095
0
Diagnosis / Prognosis
Query!
Intervention code [2]
323096
0
Early Detection / Screening
Query!
Comparator / control treatment
No control group is used. Rapid assessments (index tests) for each child will be compared to standardised, reliable and valid comprehensive assessments (reference tests) administered to the same child for nine neurodevelopmental domains. Index and reference tests will be compared to determine the accuracy of index tests in: (1) identifying impairment in each domain; and (2) diagnosing FASD.
Index tests:
Rapid Neurodevelopmental Assessment: Australian Edition (RNDA ): motor, cognition, language, memory, attention, affect regulation, adaptive behavior
Behavior Assessment System for Children, 3rd Edition (BASC-3 ): academic achievement, attention, affect regulation, executive function, adaptive behaviour
Reference tests:
- Movement Assessment Battery for Children: 2nd Edition (M-ABC 2 ) or Bruininks-Oseretsky Test of Motor Proficiency, 2nd Edition (BOT-2): motor
- Wechsler Intelligence Scale for Children, Version 5 (WISC-V), Australian and New Zealand Standardised Edition: cognition
- Clinical Evaluation of Language Fundamentals, Version 5 (CELF-5) or equivalent language assessment validated for an Aboriginal and Torres Strait Islander population: language
- Wechsler Individual Achievement Test, 3rd Edition (WIAT-III) or Wide Range Achievement Test, 5th Edition (WRAT-5 ) or Woodcock-Johnson Achievement Test, 4th Edition, Australasian Adaptation: academic achievement
- Children’s Memory Scale (CMS): memory
- Connors, 3rd Edition: attention
- Behavior Rating Inventory of Executive Function, 2nd Edition (BRIEF–2): executive function
- Adaptive Behavior Assessment System, 3rd Edition (ABAS-3) or Vineland Adaptive Behavior Scales, Third Edition (Vineland-3): adaptive behavior
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
330724
0
Rapid assessments (index tests) will be compared to standardised, reliable and valid comprehensive assessments (reference tests), across nine neurodevelopmental domains. Index and reference tests will be compared to determine the accuracy of index tests in diagnosing FASD. All index and reference test scores will be assessed in combination to determine the diagnostic status of FASD. Index tests: Rapid Neurodevelopmental Assessment: Australian Edition (RNDA ) Behavior Assessment System for Children, 3rd Edition (BASC-3 ) Reference tests: - Movement Assessment Battery for Children: 2nd Edition (M-ABC 2 ) or Bruininks-Oseretsky Test of Motor Proficiency, 2nd Edition (BOT-2) - Wechsler Intelligence Scale for Children, Version 5 (WISC-V), Australian and New Zealand Standardised Edition - Clinical Evaluation of Language Fundamentals, Version 5 (CELF-5) or equivalent language assessment validated for an Aboriginal and Torres Strait Islander population - Wechsler Individual Achievement Test, 3rd Edition (WIAT-III) or Wide Range Achievement Test, 5th Edition (WRAT-5 ) or Woodcock-Johnson Achievement Test, 4th Edition, Australasian Adaptation - Children’s Memory Scale (CMS) - Connors, 3rd Edition - Behavior Rating Inventory of Executive Function, 2nd Edition (BRIEF – 2) - Adaptive Behavior Assessment System, 3rd Edition (ABAS-3) or Vineland Adaptive Behavior Scales, Third Edition (Vineland-3)
Query!
Assessment method [1]
330724
0
Query!
Timepoint [1]
330724
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Primary outcome [2]
330725
0
Index tests (RNDA gross and fine motor subscale) will be compared to standardised, reliable and valid reference tests [Movement Assessment Battery for Children: 2nd Edition (M-ABC 2 ) or Bruininks-Oseretsky Test of Motor Proficiency, 2nd Edition (BOT-2)] to determine the accuracy of index tests in identifying impairment in the motor domain of neurodevelopment. The gross and fine motor index subscales will be analysed as a composite for motor impairment.
Query!
Assessment method [2]
330725
0
Query!
Timepoint [2]
330725
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Primary outcome [3]
330773
0
Index tests (RNDA cognition subscale) will be compared to standardised, reliable and valid reference tests [Wechsler Intelligence Scale for Children, Version 5 (WISC-V), Australian and New Zealand Standardised Edition] to determine the accuracy of index tests in identifying impairment in the cognition domain of neurodevelopment.
Query!
Assessment method [3]
330773
0
Query!
Timepoint [3]
330773
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [1]
407323
0
Primary Outcome 4:
Index tests (RNDA language subscale) will be compared to standardised, reliable and valid reference tests [Clinical Evaluation of Language Fundamentals, Version 5 (CELF-5) or equivalent language assessment validated for an Aboriginal and Torres Strait Islander population] to determine the accuracy of index tests in identifying impairment in the language domain of neurodevelopment.
Query!
Assessment method [1]
407323
0
Query!
Timepoint [1]
407323
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [2]
407343
0
Primary Outcome 5:
Index tests (BASC-3 learning problems scale) will be compared to standardised, reliable and valid reference tests [Wechsler Individual Achievement Test, 3rd Edition (WIAT-III) or Wide Range Achievement Test, 5th Edition (WRAT-5 ) or Woodcock-Johnson Achievement Test, 4th Edition, Australasian Adaptation ] to determine the accuracy of index tests in identifying impairment in the academic achievement domain of neurodevelopment.
Query!
Assessment method [2]
407343
0
Query!
Timepoint [2]
407343
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [3]
407344
0
Primary Outcome 6:
Index tests (RNDA: memory subscale) will be compared to standardised, reliable and valid reference tests [Children’s Memory Scale (CMS)] to determine the accuracy of index tests in identifying impairment in the memory domain of neurodevelopment.
Query!
Assessment method [3]
407344
0
Query!
Timepoint [3]
407344
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [4]
407345
0
Primary Outcome 7:
Index tests (BASC-3: Attention Problems clinical scale] will be compared to standardised, reliable and valid reference tests (Connors, 3rd Edition) to determine the accuracy of index tests in identifying impairment in the attention domain of neurodevelopment.
Query!
Assessment method [4]
407345
0
Query!
Timepoint [4]
407345
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [5]
407346
0
Primary Outcome 8:
Index tests (BASC-3: Executive Functioning Index score) will be compared to standardised, reliable and valid reference tests [Behavior Rating Inventory of Executive Function, 2nd Edition (BRIEF – 2)] to determine the accuracy of index tests in identifying impairment in the executive function domain of neurodevelopment.
Query!
Assessment method [5]
407346
0
Query!
Timepoint [5]
407346
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [6]
407519
0
Primary Outcome 9:
Index tests (BASC-3: Anxiety and Depression clinical scale] will be compared to standardised, reliable and valid reference tests [Previous diagnostic status (depression / anxiety)] to determine the accuracy of index tests in identifying impairment in the affect regulation domain of neurodevelopment.
Query!
Assessment method [6]
407519
0
Query!
Timepoint [6]
407519
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [7]
407520
0
Primary Outcome 10: Index tests (RNDA: Self care subscale) will be compared to standardised, reliable and valid reference tests [Adaptive Behavior Assessment System, 3rd Edition (ABAS-3) or Vineland Adaptive Behavior Scales, Third Edition (Vineland-3)] to determine the accuracy of index tests in identifying impairment in the Adaptive Behavior domain of neurodevelopment.
Query!
Assessment method [7]
407520
0
Query!
Timepoint [7]
407520
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [8]
407521
0
Secondary Outcome 1: Diagnostic accuracy of index tests in diagnosing other neurodevelopmental disorders of childhood that can either co-occur with FASD, or occur independently, such as attention-deficit hyperactivity disorders and autism spectrum disorders. All index and reference test scores will be assessed in combination to determine the diagnostic status of other disorders. Index tests: Rapid Neurodevelopmental Assessment: Australian Edition (RNDA ) Behavior Assessment System for Children, 3rd Edition (BASC-3 ) Reference tests: - Movement Assessment Battery for Children: 2nd Edition (M-ABC 2 ) or Bruininks-Oseretsky Test of Motor Proficiency, 2nd Edition (BOT-2) - Wechsler Intelligence Scale for Children, Version 5 (WISC-V), Australian and New Zealand Standardised Edition - Clinical Evaluation of Language Fundamentals, Version 5 (CELF-5) or equivalent language assessment validated for an Aboriginal and Torres Strait Islander population - Wechsler Individual Achievement Test, 3rd Edition (WIAT-III) or Wide Range Achievement Test, 5th Edition (WRAT-5 ) or Woodcock-Johnson Achievement Test, 4th Edition, Australasian Adaptation - Children’s Memory Scale (CMS) - Connors, 3rd Edition - Behavior Rating Inventory of Executive Function, 2nd Edition (BRIEF – 2) - Adaptive Behavior Assessment System, 3rd Edition (ABAS-3) or Vineland Adaptive Behavior Scales, Third Edition (Vineland-3)
Query!
Assessment method [8]
407521
0
Query!
Timepoint [8]
407521
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [9]
407522
0
Secondary Outcome 2:
The direct healthcare costs of index tests will be compared to reference tests.
Query!
Assessment method [9]
407522
0
Query!
Timepoint [9]
407522
0
Healthcare costs will be collected by survey at the conclusion of index and reference tests. This survey was designed specifically for the study.
Query!
Secondary outcome [10]
407523
0
Secondary Outcome 3:
The indirect cost savings associated with diagnosing FASD using index tests will be compared to reference tests.
Query!
Assessment method [10]
407523
0
Query!
Timepoint [10]
407523
0
Healthcare costs will be collected by survey at the conclusion of index and reference tests. This survey was designed specifically for the study.
Query!
Secondary outcome [11]
407524
0
Secondary Outcome 4:
The direct healthcare costs for index tests and reference tests being delivered in primary healthcare settings will be compared to specialist clinic settings.
Query!
Assessment method [11]
407524
0
Query!
Timepoint [11]
407524
0
Healthcare costs will be collected by survey at the conclusion of index and reference tests. This survey was designed specifically for the study.
Query!
Secondary outcome [12]
407525
0
Secondary Outcome 5:
The indirect cost savings of completing index tests and reference tests in primary healthcare settings will be compared to specialist clinic settings.
Query!
Assessment method [12]
407525
0
Query!
Timepoint [12]
407525
0
Healthcare costs will be collected by survey at the conclusion of index and reference tests. This survey was designed specifically for the study.
Query!
Secondary outcome [13]
407967
0
Index tests (BASC-3: Adaptive Skills composite) will be compared to standardised, reliable and valid reference tests [Adaptive Behavior Assessment System, 3rd Edition (ABAS-3)] to determine the accuracy of index tests in identifying impairment in the Adaptive Behavior, social skills and social communication domain of neurodevelopment.
Query!
Assessment method [13]
407967
0
Query!
Timepoint [13]
407967
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [14]
407968
0
Index tests [RNDA: Behavior subscale (attention items)] will be compared to standardised, reliable and valid reference tests (Connors, 3rd Edition) to determine the accuracy of index tests in identifying impairment in the attention domain of neurodevelopment.
Query!
Assessment method [14]
407968
0
Query!
Timepoint [14]
407968
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Secondary outcome [15]
407969
0
Index tests [RNDA: Behavior subscale (affective items)] will be compared to standardised, reliable and valid reference tests [Previous diagnostic status (depression / anxiety)] to determine the accuracy of index tests in identifying impairment in the affect regulation domain of neurodevelopment.
Query!
Assessment method [15]
407969
0
Query!
Timepoint [15]
407969
0
Assessments will be collected within 6 months of recruitment. The time between the first and last test within the assessment battery will not exceed 6 months.
Query!
Eligibility
Key inclusion criteria
Inclusion criteria will be English-speaking children with suspected prenatal alcohol exposure, between 6- to 16-years-old. Because children with suspected prenatal alcohol exposure are heterogeneous, FASD along with other comorbid diagnoses are possible outcomes of the assessment, so additional DSM-V neurodevelopmental diagnoses are expected and will not be exclusionary.
Query!
Minimum age
6
Years
Query!
Query!
Maximum age
16
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
There are no exclusion criteria.
Query!
Study design
Purpose
Screening
Query!
Duration
Cross-sectional
Query!
Selection
Defined population
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Sites currently conduct between one to four FASD or neurodevelopmental assessments per month as part of usual care. Based on assessments completed in the past year, over the 3 year data collection period, a total recruitment sample of 288 children will be available. Allowing for a 30% drop-out, a final sample of 200 participantswill be possible. The final sample will aim to have 50% representation from rural and remote sites, and 50% representation of First Nations children.
The probability of FASD diagnosis in this sample will be moderate (estimated at 50-60% by our partners) because children are referred to the services for an assessment due to significant developmental delays and suspected prenatal alcohol exposure. Two hundred participants provide a large enough sample for precise estimates of sensitivity and specificity. For example, assuming 55% of the sample have FASD, we will be able to detect a difference of 7.5% from an expected sensitivity of 80%, and a difference of 6% from an expected specificity of 90%.
Standard statistical methods for estimating diagnostic accuracy will be used including: sensitivity, specificity, positive and negative predictive values, receiver operating curves, and likelihood ratios.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
4/04/2022
Query!
Actual
11/04/2022
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
200
Query!
Accrual to date
40
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD,VIC
Query!
Funding & Sponsors
Funding source category [1]
310968
0
Government body
Query!
Name [1]
310968
0
National Health and Medical Research Council (NHMRC)
Query!
Address [1]
310968
0
National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601
Query!
Country [1]
310968
0
Australia
Query!
Funding source category [2]
310986
0
Government body
Query!
Name [2]
310986
0
Aboriginal and Torres Strait Islander Health Division, Queensland Health
Query!
Address [2]
310986
0
Level 9/ 33 Charlotte Street Brisbane QLD 4001
Query!
Country [2]
310986
0
Australia
Query!
Funding source category [3]
310987
0
Government body
Query!
Name [3]
310987
0
Health Workforce Queensland
Query!
Address [3]
310987
0
Level 4/348 Edward St, Brisbane City QLD 4000
Query!
Country [3]
310987
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Griffith University
Query!
Address
1 Parklands Dr, Southport QLD 4215
Query!
Country
Australia
Query!
Secondary sponsor category [1]
312297
0
None
Query!
Name [1]
312297
0
Query!
Address [1]
312297
0
Query!
Country [1]
312297
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
310526
0
Children's Health QLD Hospital and Health Service HREC
Query!
Ethics committee address [1]
310526
0
Level 7, Centre for Children’s Health Research
Queensland Children’s Hospital Precinct
62 Graham Street, South Brisbane QLD 4101
Query!
Ethics committee country [1]
310526
0
Australia
Query!
Date submitted for ethics approval [1]
310526
0
20/05/2020
Query!
Approval date [1]
310526
0
15/09/2020
Query!
Ethics approval number [1]
310526
0
HREC/20/QCHQ/63173
Query!
Ethics committee name [2]
310549
0
Griffith University Human Research Ethics Committee
Query!
Ethics committee address [2]
310549
0
Griffith University, Gold Coast Campus, Parklands Drive, Southport Queensland, 4222
Query!
Ethics committee country [2]
310549
0
Australia
Query!
Date submitted for ethics approval [2]
310549
0
22/09/2020
Query!
Approval date [2]
310549
0
25/09/2020
Query!
Ethics approval number [2]
310549
0
2020/743
Query!
Summary
Brief summary
Fetal Alcohol Spectrum Disorder (FASD) is a chronic disability with costly impact on families, as well as educational, health, and justice services. The prevalence of FASD ranges from 1-10%, and is as high as 19% in some remote areas. However, many affected children go undetected. Better early detection systems are needed to deliver interventions that can effectively support structural and functional brain development. Current diagnostic practices involve a lengthy assessment process that extends to multiple days per child and requires specialist expertise. Capacity to identify FASD is restricted because specialist teams are expensive, have 2-year waitlists, and exist only in urban areas. Innovative, flexible solutions are needed to ensure that children in remote Indigenous communities have access to early diagnostic services. Through extensive pilot work and strong partnerships with remote Indigenous communities, our team has co-created an innovative, culturally sensitive, tiered neurodevelopmental assessment that can be conducted in routine primary care. The current project will compare the accuracy of a rapid, tiered assessment protocol to a comprehensive assessment protocol used in Queensland specialist FASD clinics. The cost effectiveness of the tiered assessment will be assessed to further extend translation. The outcome will be (i) an expedient, validated FASD screening and assessment protocol, (ii) a culturally-sensitive protocol that has widespread applicability to remote Indigenous communities, and (iii) reduced costs and economic net benefits for families and health services.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
117962
0
A/Prof Dianne Shanley
Query!
Address
117962
0
G40, Level 7, Room 7.89
School of Applied Psychology
Griffith University Gold Coast campus
1 Parklands Drive
Southport QLD 4215
Query!
Country
117962
0
Australia
Query!
Phone
117962
0
+61 7 5678 8132
Query!
Fax
117962
0
Query!
Email
117962
0
[email protected]
Query!
Contact person for public queries
Name
117963
0
Dr Wei Liu
Query!
Address
117963
0
G40, Level 7, Room 7.50
Menzies Health Institute of Queensland
Griffith University Gold Coast Campus
1 Parklands Drive
Southport QLD 4215
Query!
Country
117963
0
Australia
Query!
Phone
117963
0
+61 7 5678 0367
Query!
Fax
117963
0
Query!
Email
117963
0
[email protected]
Query!
Contact person for scientific queries
Name
117964
0
A/Prof Dianne Shanley
Query!
Address
117964
0
G40, Level 7, Room 7.89
School of Applied Psychology
Griffith University Gold Coast campus
1 Parklands Drive
Southport QLD 4215
Query!
Country
117964
0
Australia
Query!
Phone
117964
0
+61 7 5678 8132
Query!
Fax
117964
0
Query!
Email
117964
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Data will involve sensitive health information for children, and will involve sensitive health information about Aboriginal and Torres Strait Islander children.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
15377
Study protocol
[email protected]
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Diagnostic Accuracy and economic value of a Tiered Assessment for Fetal Alcohol Spectrum Disorder (DATAforFASD): Protocol.
2023
https://dx.doi.org/10.1136/bmjopen-2022-071004
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF